Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.52 |
| ▸ | ALB | P02768 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 7/20 | 0.49 |
| ▸ | CA1 | P00915 | 6/20 | 0.49 |
| ▸ | CA2 | P00918 | 6/20 | 0.49 |
| ▸ | CA12 | O43570 | 5/20 | 0.49 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.49 |
| ▸ | CA7 | P43166 | 1/20 | 0.49 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.46 |
| ▸ | HTR3A | P46098 | 2/20 | 0.45 |
| ▸ | HTRA2 | O43464 | 3/20 | 0.44 |
| ▸ | HTRA1 | Q92743 | 3/20 | 0.44 |
| ▸ | ELF3 | P78545 | 1/20 | 0.43 |
| ▸ | MED23 | Q9ULK4 | 1/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26230948 | 0.96 | FOLH1 (0.53) | FOLH1ALBCA9CA1CA2 | |
| SCHEMBL21183304 | 0.93 | FOLH1 (0.53) | FOLH1ALBCA9CA1CA2 | |
| SCHEMBL20843781 | 0.92 | FOLH1 (0.56) | FOLH1ALBCA9CA1CA2 | |
| SCHEMBL17245299 | 0.92 | FOLH1 (0.56) | FOLH1ALBCA9CA1CA2 | |
| SCHEMBL15505788 | 0.91 | FOLH1 (0.54) | FOLH1ALBCA9CA1CA2 | |
| SCHEMBL26230941 | 0.91 | FOLH1 (0.46) | FOLH1ALBCA9CA1CA2 | |
| SCHEMBL21183297 | 0.90 | FOLH1 (0.54) | FOLH1ALBCA9CA1CA2 | |
| SCHEMBL22414021 | 0.89 | FOLH1 (0.54) | FOLH1ALBCA9CA1CA2 | |
| SCHEMBL20622392 | 0.89 | FOLH1 (0.54) | FOLH1ALBCA9CA1CA2 | |
| SCHEMBL17245794 | 0.88 | FOLH1 (0.55) | FOLH1ALBCA9CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11759480-B2 | Compositions and methods for CAR T cell therapy | ENDOCYTE, INC. (US) | 2023-09-19 | — | — | US | disclosed |
| US-20200405760-A1 | COMPOSITIONS AND METHODS FOR CAR T CELL THERAPY | ENDOCYTE, INC. | 2020-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11759480-B2 | Compositions and methods for CAR T cell therapy | CD47, PBK, GZMB | FOLH1 186/4885ALB 2876/4885CA9 542/4885 |
| US-20200405760-A1 | COMPOSITIONS AND METHODS FOR CAR T CELL THERAPY | CD47, PBK, GZMB | FOLH1 186/4885ALB 2876/4885CA9 542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.